Combining MCMC with ‘sequential’ PKPD modelling
暂无分享,去创建一个
Beat Neuenschwander | Gordon Graham | David J. Lunn | Nicky Best | David Lunn | David Spiegelhalter | D. Spiegelhalter | N. Best | B. Neuenschwander | G. Graham
[1] W. K. Hastings,et al. Monte Carlo Sampling Methods Using Markov Chains and Their Applications , 1970 .
[2] Roderick J. A. Little,et al. Statistical Analysis with Missing Data , 1988 .
[3] David J. Lunn,et al. Bayesian Analysis of Population Pharmacokinetic/Pharmacodynamic Models , 2005 .
[4] David J. Spiegelhalter,et al. Estimation of population pharmacokinetics using the Gibbs sampler , 1995, Journal of Pharmacokinetics and Biopharmaceutics.
[5] Leon Aarons,et al. A population analysis of the pharmacokinetics and pharmacodynamics of midazolam in the rat , 1991, Journal of Pharmacokinetics and Biopharmaceutics.
[6] David J. Spiegelhalter,et al. Bayesian graphical modelling: a case‐study in monitoring health outcomes , 2002 .
[7] Peter E. Rossi,et al. Case Studies in Bayesian Statistics , 1998 .
[8] Adrian F. M. Smith,et al. Sampling-Based Approaches to Calculating Marginal Densities , 1990 .
[9] Roderick J. A. Little. Regression with Missing X's: A Review , 1992 .
[10] Amy Racine-Poon,et al. "The Bayesian approach to population pharmacokinetic/pharmacodynamic modeling". In: Case Studies in Bayesian Statistics (Vol IV), Lecture Notes in Statistics , 1999 .
[11] Ivelina Gueorguieva,et al. Diazepam Pharamacokinetics from Preclinical to Phase I Using a Bayesian Population Physiologically Based Pharmacokinetic Model with Informative Prior Distributions in Winbugs , 2006, Journal of Pharmacokinetics and Pharmacodynamics.
[12] Xiao-Li Meng,et al. Multiple-Imputation Inferences with Uncongenial Sources of Input , 1994 .
[13] Arthur P. Dempster,et al. The direct use of likelihood for significance testing , 1997, Stat. Comput..
[14] Stephen J. Roberts,et al. Probabilistic Modeling in Bioinformatics and Medical Informatics , 2010 .
[15] Donald Geman,et al. Stochastic Relaxation, Gibbs Distributions, and the Bayesian Restoration of Images , 1984, IEEE Transactions on Pattern Analysis and Machine Intelligence.
[16] David J. Lunn,et al. Markov Chain Monte Carlo Techniques for Studying Interoccasion and Intersubject Variability: Application to Pharmacokinetic Data , 1997 .
[17] Thomas M. Ludden,et al. Estimation of Population Pharmacokinetic Parameters in the Presence of Non-compliance , 2003, Journal of Pharmacokinetics and Pharmacodynamics.
[18] Jon Wakefield,et al. Bayesian Analysis of Population PK/PD Models: General Concepts and Software , 2002, Journal of Pharmacokinetics and Pharmacodynamics.
[19] Roderick J. A. Little,et al. Statistical Analysis with Missing Data: Little/Statistical Analysis with Missing Data , 2002 .
[20] Jon Wakefield,et al. An Expected Loss Approach to the Design of Dosage Regimens Via Sampling‐Based Methods , 1994 .
[21] Lewis B. Sheiner,et al. Simultaneous vs. Sequential Analysis for Population PK/PD Data II: Robustness of Methods , 2003, Journal of Pharmacokinetics and Pharmacodynamics.
[22] David J. Lunn,et al. The Pharmacokinetics of Saquinavir: A Markov Chain Monte Carlo Population Analysis , 1998, Journal of Pharmacokinetics and Biopharmaceutics.
[23] N. Metropolis,et al. Equation of State Calculations by Fast Computing Machines , 1953, Resonance.
[24] Steffen L. Lauritzen,et al. Independence properties of directed markov fields , 1990, Networks.
[25] Lewis B. Sheiner,et al. Simultaneous vs. Sequential Analysis for Population PK/PD Data I: Best-Case Performance , 2003, Journal of Pharmacokinetics and Pharmacodynamics.
[26] Gordon Graham,et al. Determination of an Optimal Dosage Regimen Using a Bayesian Decision Analysis of Efficacy and Adverse Effect Data , 2002, Journal of Pharmacokinetics and Pharmacodynamics.
[27] N. G. Best,et al. WinBUGS User Manual: Version 1.4 , 2001 .